Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

Download All
Review the latest multidisciplinary strategies for optimizing care of patients with CLL, including discussion of effective patient education on treatment selection and toxicity management. Learn from the experts with focused commentaries, brief MedicalMinute slide/audio presentations, case review modules, and an Interactive Decision Support Tool that provides personalized management recommendations for treatment selection.
person default
Shuo Ma, MD, PhD
person default
Lindsey Roeker, MD
Jennifer Woyach, MD


As CLL treatment paradigms continue to shift and become more complex, it is essential to provide patients with education on available treatment options and to engage in open discussions about their care. In this expert commentary, best practices on these concepts are discussed.

Jennifer Woyach, MD Released: November 17, 2021

Review an expert discussion of investigational treatment strategies for patients with chronic lymphocytic leukemia, including novel BTK and PI3K inhibitors, combination treatment with BTK and BCL-2 inhibitors, and CAR T-cell therapy.

person default Shuo Ma, MD, PhD Released: April 21, 2022

In this commentary, an expert faculty discusses key considerations and shared decision-making in choosing treatment for a patient with CLL.

person default Lindsey Roeker, MD Released: July 7, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
CLL Society Logo
Supported by educational grants from
AbbVie Inc.
Eli Lilly and Company
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc.
TG Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings